Hypertrophic cardiomyopathy: a modern view of the problem

Hypertrophic cardiomyopathy (HCM) is the most common genetic heart disease, with a prevalence of approximately 1 in 500 among the adult cohort. It is a common etiological factor of sudden cardiac death in the young and a common cause of morbidity and mortality in all age groups. HCM is characterized...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Amina M. Alieva, Ilda I. Almazova, Elena V. Reznik, Tatyana V. Pinchuk, Irina E. Baykova, Vladimir A. Kislyakov, Vyacheslav I. Svetlakov, Irina V. Kovtyukh, Sergey A. Korvyakov, Alik M. Rakhaev, Igor G. Nikitin
Formato: article
Lenguaje:EN
RU
Publicado: Concilium Medicum 2020
Materias:
Acceso en línea:https://doaj.org/article/4d7aa0ce70364160b478baf77378074e
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
Descripción
Sumario:Hypertrophic cardiomyopathy (HCM) is the most common genetic heart disease, with a prevalence of approximately 1 in 500 among the adult cohort. It is a common etiological factor of sudden cardiac death in the young and a common cause of morbidity and mortality in all age groups. HCM is characterized by a complex pathophysiology, which is manifested by a heterogeneous clinical picture. The mechanism of development of this variant of hypertrophy is not fully understood. Currently, only a part of the genetic mutations that correlate with the development of this pathology has been identified. In this regard, the issue of genetic diagnosis of HCM is very relevant, as it will allow us to conduct advanced screening. A very important task is to develop a personalized approach in the conservative and surgical treatment of people suffering from this variant of cardiopathy.